Therapeutic interventions in osteoporosis.
Sutcliffe
Anne
A
Musculoskeletal Unit, Newcastle upon Tyne Hospitals NHS Trust.
D045930:Anabolic Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D020249:Hormone Replacement Therapy; D006801:Humans; D009652:Norpregnenes / Q000627:therapeutic use; D010024:Osteoporosis / Q000188:drug therapy* / Q000451:nursing; D010281:Parathyroid Hormone / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D006113:United Kingdom; D014807:Vitamin D / Q000627:therapeutic use
D045930:Anabolic Agents; D004164:Diphosphonates; D009652:Norpregnenes; D010281:Parathyroid Hormone; D014807:Vitamin D; D020849:Raloxifene Hydrochloride; D011374:Progesterone; D002116:Calcitonin; C027385:tibolone; D002118:Calcium